Corin Share Discussion Threads

[gambler99] 20/5/2008 13:24

the problem is it will probably get to 220p - 210p then rocket to 270p in one
day!!! probably in 2 weeks or so when everyone like myself is fed up trading
this, or holding for a bounce....worst position i've held for a long time
.....still can't believe i broke my own stop loss rules...

[gambler99] 20/5/2008 13:19

anyone have an opinion on this company or share movement???

very lumpy price movement up and down....not too happy trading this

as it seems quite unpredictable....i guess they are shorting it from

over the pond....or just no one buying...anyway looking at 10th of my

profit from the last 5 months being taken so far in losses on this....broken all rules regarding stop losses....very strict usually!!!

[abcd1234] 19/5/2008 08:34

loooks like you're getting your bounce now

[gambler99] 16/5/2008 22:19

a note to myself...down 50%....interesting...will it rally next week

back to 270p...who knows..obviously market not happy with news....

let's hope we have a reverse situation....300,000 shares bought at the end

of play today 2:1 buying now.- a good sign :)....

[gambler99] 16/5/2008 15:07

well as far as rebounds go that has got to be the worst in history.....

down 45%...no bounce...i can't ever recall such a bad perfomance!

[gambler99] 16/5/2008 11:24

Telegraph today:


In recent months, Corin's shares have been boosted by hopes that Stryker, which is one the world's largest manufacturer of orthopaedic devices, was mulling a takeover.

However, Mr Jantet said that this latest news meant that a bid was unlikely. "We think it unlikely that Stryker will bid for Corin in the short term and absent a bid we think the shares are worth 300p."

[cyclingnut] 16/5/2008 10:15

hmmm...not looking to clever...I will try and buy into strength as opoosed to buying into weakness as it always end up lower!! Any of you guys in MDX!

[abcd1234] 16/5/2008 09:37

yes, looks like it might be due a bounce here
wonder just how many others are watching too ;O)

[gambler99] 16/5/2008 09:01

who can say...but it has dropped 45% on news.
and seems to be bottoming, worth a punt i think

[cyclingnut] 16/5/2008 08:53

thinking of opening a CFD on this puppy...........any thoughts on the bottom or has it got further to go?

[gambler99] 15/5/2008 19:29

time for a bounce?

[wjccghcc] 18/4/2008 09:43

What I find hard to understand is if they have such a good product, why are sales in every country apart from the US flat or down?

[robow] 18/4/2008 09:25

from todays Independent


Corin Group

Our view: Buy

Share price: 442.5p (+13.5p)

Investors worried about where to park their investments will be pleased to hear of Corin, which makes orthopaedic medical devices. In the current market, it is hard to find a group that is both defensive and has a good story to tell about the future.

For several years the company has been bumbling about without making a serious impact on the consciousness of investors. That was before it happened upon Cormet, a hip resurfacing system, distributed in the US by Stryker. On the back of Cormet, the company's sales in the US are up 35 per cent on last year, with profits up 86 per cent. All this comes in the face of a weak dollar, which the interim chief executive, Simon Hartley, reckons has cost the group £800,000 in profit. The company has also suffered from a general US Department of Justice investigation into the payment of surgeons for training. Mr Hartley says this is now resolved and payments have been approved.

Analysts at Oriel Securities say the group is in "start-up phase" in the US, and assuming it can keep pace with orders, it is on to a winner.

Those at Nomura say that the non-US results are not too impressive. Mr Hartley says that products targeting Europe and Australia are in development, but concedes they will take some time to come to fruition.

Corin looks set to have a pretty good year. Now that the worries about surgeons' training have been resolved and largely because Stryker is on board as the group's distributor, there cannot be many reasons to avoid Corin stock. Buy.

[chester] 04/2/2008 08:30

Continuing nicely today.

[chester] 01/2/2008 08:41

Came down to the 377ma yesterday, bounced off it and also bounced off the 50% Fib retrace from the Sept 06 low to 12th Oct 07 High. Looks good to me. I'm in for a few.

[cr4zyness] 30/11/2007 09:50

Monday November 26, 2007
John Britner, 51, of the Williamsport area, has walked approximately two miles every day since late October thanks to a hip-resurfacing procedure he had done on his left hip in early October. He's using a cane, temporarily, as he recovers. "Before the operation, if I'd have walked a half mile, I'd have been lucky. It was just too painful," said Britner, seen here walking across the Chesapeake and Ohio Canal aqueduct last week. (Photo credit: Kevin G. Gilbert / Staff Photographer)


Hip procedure preserves leg
Resurfacing is an alternative to replacement and might last longer
By JULIE E. GREENE [e-mail]


Before John Britner's hip surgery in early October, walking was difficult and bending over to pick produce was painful for the Williamsport-area produce farmer.


During his 51 years, Britner's left hip had worn out and he was diagnosed with osteoarthritis in which joint cartilage breaks down causing pain with repetitive use of the joint.


Britner faced a decision - get a total hip replacement or try a procedure called hip resurfacing that is fairly new in the U.S. but has been done for years in Europe.


The deciding factor for Britner was thinking ahead to the possibility of needing a second hip operation. Several orthopedic experts believe the hip-resurfacing option could end up lasting longer than a total hip replacement, said Dr. Ralph T. Salvagno, orthopedic surgeon at the Center for Joint Surgery & Sports Medicine at Robinwood Medical Center.


Britner could always get the total hip replacement later, but he preferred the hip-resurfacing option, which preserves more of the femur than does hip replacement.



Hip resurfacing


Hip resurfacing is an alternative suitable for active women who are 60 or younger and men who are 65 or younger because of their bone strength, active lifestyle and the expected life span of the implants, Salvagno said.


The key is the strength of the femur. As people get older, they tend to get osteoporosis, resulting in weaker bones and a higher risk that the femoral neck - the thin top of the femur bone - could snap off, Salvagno said.


Salvagno tells all his patients that the femoral neck breaking is a risk during surgery and during the first three months of recovery. If that happens, the patient will need a total hip replacement, in which the stem of the metal ball is longer so it goes further into the femur than hip-resurfacing implants.


The risk of the procedure failing - of the femoral neck cracking - is twice as high in women, though it's still a small percentage, Salvagno said. The risk of failure in women is about 2 out of 100 cases.


Even if a patient opts for hip resurfacing, if the surgeon discovers during the procedure that the bone is not in good enough shape, a total hip replacement would be done instead, Salvagno said.


With hip resurfacing, the neck of the femur is reshaped and capped with a metal ball, creating a new ball for the joint. The socket in the hip bone is cleaned out, and a metal socket is inserted.


Once you have a total hip replacement, you can't have resurfacing done because there isn't enough bone left.



History of resurfacing


Hip resurfacing dates back to about the early 1950s and became further refined in the mid-1970s, according to the Joint Replacement Institute's Web site.


Dr. Harlan Amstutz, who is founding director of the Joint Replacement Institute in Los Angeles, did some pioneering work in the 1970s, but Salvagno said other surgeons had difficulty duplicating Amstutz's work.


The implants Salvagno uses for his patients, including Britner, are called the Birmingham Hip Resurfacing System, named for the place in England where work was done on the components manufactured by Smith & Nephew.


The U.S. Food and Drug Administration approved the Birmingham Hip Resurfacing System in May 2006, though the FDA had approved resurfacing procedures for the shoulder several years ago, Salvagno said.


The FDA approved the Cormet Hip Resurfacing System, applied for by Corin USA, in July 2007, according to the FDA's Web site.


Salvagno started offering Birmingham Hip Resurfacing this past spring after working with Dr. Ronan Treacy in England, who had been doing the procedure for about 10 years.


Salvagno said he was skeptical of hip resurfacing before his trip because hip resurfacings done by doctors other than Amstutz hadn't lasted as long as Amstutz's.


His skepticism was alleviated during his trip when he determined the Birmingham technique was reproducible. So far he has done three Birmingham hip resurfacings, all on men.



Thinking long-term


Like John Britner, Williamsport-area resident Bill Rhodes also considered the longevity of hip resurfacing and the possibility of needing a future hip procedure when considering his options for his left hip.


Rhodes' hip had deteriorated due to an old motorcycle injury and arthritis.


His thinking was if he had a total hip replacement and needed another in 10 years, he'd be handicapped by age 63 if his femur wasn't strong enough to sustain another hip replacement.


Rhodes, 43 and a carpenter, decided to go with the resurfacing.


British studies of the Birmingham Hip Replacement System show there is an 85 percent survival rate for resurfacing components implanted for eight to 10 years, Salvagno said. If they fail, it's usually early because the femoral neck breaks.


A total hip replacement typically lasts 15 to 20 years, but hip resurfacings done by Amstutz have lasted 20 to 25 years, Salvagno said. The procedure Amstutz used 20 to 25 years ago is close enough to Birmingham hip replacement that the belief by Salvagno and other colleagues who attended the first annual Comprehensive Hip Resurfacing Course in Annapolis earlier this month is that Birmingham hip resurfacings could last just as long, Salvagno said.


Salvagno said he doesn't think there is a significant difference in recovery between hip resurfacing and total hip replacement. The use of a larger head or ball with resurfacing creates less risk of the hip popping out.


How much insurance covers hip resurfacing depends on the insurance plan.


The list cost for hip resurfacing components is approximately $10,000, compared with approximately $8,000 to $9,000 for metal-on-metal total hip replacement pieces and approximately $6,000 for metal-on-plastic total hip replacement components, Salvagno said.


One long-term concern with metal-on-metal components, whether it's for resurfacing or total hip replacement, is the long-term effects of metal ions from wear on the components, Salvagno said.


As the joint is used and components become worn, metal debris and ions - electrically charged atoms - are generated. The debris or small metal particles clear the body naturally, but medical officials don't know what happens to the metal ions that get absorbed into the body, Salvagno said. The ions might disintegrate. The unknowns include the risk for cancer and kidney disease.


Rhodes said the unknown risks were worth it, and with hip resurfacing the implants could last significantly longer than with a total hip replacement.


"I lived a life where I could hardly get around with pain and medication," Rhodes said. "Now I take nothing and I'm walking around like a new person."




--------------------------------------------------------------------------------




More on the Web


To learn more about hip resurfacing, visit:


Food and Drug Administration site, which includes who's not eligible for the procedure, at www.fda.gov/cdrh/mda/docs/p040033.html.


Manufacturer Smith & Nephew's site at www.birminghamhipresurfacing.com.


Joint Replacement Institute in Los Angeles at www.jri-oh.com/jri_hip_resurfacing.php.

[cr4zyness] 31/10/2007 08:09

Wesley Medical Offers New Hip Surgery

Monday, Oct 29, 2007 - 03:25 PM

With over 43 million Americans suffering from arthritis, total hip replacement surgery is not an uncommon procedure. Now, an alternative to total hip replacement surgery allows patients to resume many of the activities they enjoyed pre-operatively, while conserving more of their natural bone and helping minimize their risk of dislocation1.

Dr. Richard Conn, Orthopaedic Surgeon with Southern Bone & Joint Specialists, P.A. was the first physician in the United States to perform a hip resurfacing procedure with the Cormet Hip Resurfacing System, offered exclusively by Stryker in the US, since receiving FDA approval. "I think the Cormet Hip Resurfacing system is poised to be a key option for me as a hip surgeon in the treatment of my younger, more active arthritic hip patients," said Dr. Conn.

The Cormet Hip Resurfacing System provides patients with two important benefits. First, patients have more of their natural bone preserved. In this innovative process, the end of the thigh bone, or femur, is capped with a strong metal covering - much like the capping of a tooth. Because the femoral head is simply reshaped and "resurfaced" rather than removed, the procedure is bone conserving. Secondly, the large diameter femoral head may reduce the risk of dislocation, and often provides a more natural performance than traditional total hip arthroplasty1. Dr. Conn believes this hip system is the right choice for many of his patients. "With the very large heads of this femoral resurfacing system, it gives you inherent stability and also improves the potential for greater motion and mobility, therefore allowing individuals to be more active and do more things," said Conn. Mr. Orville Todd, 60, was the first patient to have the procedure. "I had hip pain for about five years, and it just kept getting worse. Finally it got to the point where I couldn't stand it anymore, said Todd." "It made my job difficult -- the longer the day went, the more I'd hurt." Since the surgery Mr. Todd has a new lease on life. "I can do most anything now, he said." "Knowing what I know now, I would have gone in for this three years ago. It seems like it's going to be a long-term solution for me."


Should the implant need replacing at some time in the future, a conventional total hip replacement can typically be used. This makes hip resurfacing an attractive option for younger and more active osteoarthritis patients.

Interest in hip resurfacing procedures is on the rise globally due to the bone-conserving nature of the procedure and anticipated potential benefits related to post-operative activities and range of motion. In these procedures, surgeons replace the hip socket in much the same way as a conventional total hip, but the femoral head is resurfaced rather than removed. Hip resurfacing is viewed by many surgeons as an alternative to traditional total hip replacement to help patients return to their active lifestyles. "By selecting the right patient and using the training we've received, this procedure will be a successful treatment option for many patients," said Conn.

Jim Dagg, Director of Diagnostic Services at Wesley Medical Center made an appointment with Dr. Conn after suffering from hip pain for years and is now scheduled for the hip resurfacing procedure on November 9. "I've worked in healthcare my entire career," said Dagg. "I know a great doctor when I see one and I've done my homework. Dr. Conn is the only physician I would trust with my hip surgery." Mr. Todd agrees, "Dr. Conn was great – I'd recommend him to anybody.

Since performing the first procedure with the Cormet Hip Resurfacing System, Dr. Conn has used the system on an additional 10 patients. "Our patients' results have been really strong, which makes for very satisfied patients and a very pleased physician," said Conn. Dr. Conn trained with the surgeons who designed the Cormet Hip Resurfacing System in England, and he is a member of the surgeon-training group for the Cormet Hip having trained more than 40 physicians from across the country on how to select the appropriate patient for this procedure and how to perform the procedure.

Mr. Ron Seal, CEO for Wesley Medical Center is proud to add another "first" to the hospital's list of services and technologies available for patients. "Dr. Conn has always been on the cutting edge of new procedures, product development and technologies in the field of Orthopaedics," said Seal. "It makes us proud that he is pleased with the service and care we can help him provide to his patients here at Wesley Medical Center."

[analyst] 21/10/2007 19:27

On the morning of 18th October

[jono88] 21/10/2007 19:20

Useful article Irvbox. Do you know when it was published?

[irvbox] 18/10/2007 10:46

Found this today about Stryker

Stryker Corp. (SYK) reported late Wednesday a 21% climb in third-quarter profit behind gains in its domestic orthopedic implant and surgical equipment businesses.

The Kalamazoo, Mich., company raised its full-year sales growth guidance, excluding the impact of foreign currency, to a range of 13% to 13.5% based on expectations for growth in shipments in these businesses. Stryker kept its full- year guidance for earnings from continuing operations in check at $2.40 a share, matching analyst expectations.

The company posted third-quarter net income of $228.7 million, or 55 cents a share, up from $188.4 million, or 46 cents a share, a year ago.

Net sales climbed 18% to $1.45 billion. Analysts surveyed by Thomson Financial were expecting earnings of 55 cents a share on sales of nearly $1.4 billion.

Stryker derived $946 million of its third-quarter sales from the U.S. market, an 18% gain. Stephen P. MacMillan, Stryker's president and chief executive, said in a release that "Domestic sales were particularly strong," with orthopedic implant sales rising 16% in the home market while sales in the "MedSurg" surgical business rose 20%.

International sales also rose 18% to $507.2 million, with the help of favorable foreign currency rates.

Among Stryker's orthopedic devices, worldwide sales of replacement hips rose 9% while sales of knees climbed 16% and sales of spinal products moved up 24%, including the impact of foreign currency.

Hips have been an area of sluggishness for Stryker, particularly in the U.S., where sales increased 6% in the recent quarter. Speaking on a call with analysts, MacMillan said the domestic hip business will get some help when the company's U.S. hip resurfacing operations ramp up. He expects a "meaningful contribution" next year.

The U.S. Food and Drug Administration this summer approved a hip resurfacing product made by Corin Group PLC (CRG.LN) that Stryker is marketing in the U.S. Stryker is currently focused on comprehensive surgeon training, MacMillan said.

Overall, worldwide sales in the orthopedics business rose 15.4% to $855.9 million. Sales in the MedSurg business, which includes surgical navigation systems and endoscopy systems among other products, climbed 22% to $597.3 million.

Stryker in April announced that an FDA request for additional data on the company's OP-1 spinal putty, which promotes bone growth in spinal surgeries, would significantly delay expectations for approval. Asked about the issue again Wednesday, MacMillan repeated that analysts should "take it out of your models," and said "this could be a while."

Before the delay, the company had said it hoped for OP-1 approval this year.

Separately, MacMillan was asked a familiar question about Stryker's acquisition plans and how the company might put its cash to use. He indicated the company is mainly looking at using cash for deals and repeated that Stryker remains interested, but also said that there's no need to rush. He has said before that Stryker is interested more in product-type deals that fill voids, rather than big purchases.

"We've been fairly active poking around," but have found a lot of "premium priced" assets and don't want to overpay, MacMillan told analysts. "We don't feel any burning urgency to have to do a deal this year or whenever," he said.

Shares of Stryker slipped 8 cents to close at $72.19 on Wednesday. Shares were recently higher at $72.34 in after-hours trading.

-By Jon Kamp, Dow Jones Newswires; 312-750-4129; [e-mail]

[cyclingnut] 31/7/2007 15:11

who cares............it's flying today!!

[mjlondon] 04/7/2007 08:14

Up 6% and still going, should be a good day for CRG!